Hydrocephalus, commonly referred to as "water on the brain," is a dangerous and potentially deadly condition that can harm ...

Building a Mythos-Ready Security Program” delivers a risk register, 11 priority actions, and board briefing framework built ...

Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.

Trial Designed to Demonstrate Target Engagement, Safety, and Pharmacokinetics CLEVELAND, April 7, 2026 /PRNewswire/ -- NeuroTherapia, Inc., a clinical-stage company focused on developing oral ...

Niger Delta ex-militants, Board of Trustees (BoT), Critical Stakeholders Forum (CSF), and the Foundation for Heritage ...

The prevalence of invasive bacterial infection in young febrile infants is estimated at 1%–4%, with the highest rates in ...

Dr. Daniels is a seasoned biotechnology executive with more than two decades of experience spanning clinical development, regulatory strategy, corporate operations, and business development. He most ...

Replimune Group, Inc. stock drops after a second FDA rejection for RP1 melanoma; cash runway <12 months. Click for more on ...

HOUSTON, TX, UNITED STATES, April 1, 2026 /EINPresswire.com/ -- With the rapid evolution of cyber threats, Senthil ...

Stakeholders say decentralising Tantita pipeline surveillance would weaken coordination and reverse gains in oil theft reduction.

A content creator whose multiple sclerosis was masking the symptoms of incurable blood cancer has outlived her prognosis of ...

Pozzovivo last raced in 2024, finishing 38th at Il Lombardia while riding for VF Group-Bardiani CSF-Faizanè, but now he will ...